Catalyst Oncology

McConnell P, Dash RC, Chilukuri R, et al. The Cancer Translational Research Informatics Platform. BMC Med Inform Decis Mak. 2008 Dec 24;8(1):60. PMID: 19108734 Researchers at Duke University Medical Center and SemanticBits (Herndon, Virginia) describe a new outcomes analysis tool that allows oncologists to query clinical data from geographically dispersed patients with similar characteristics to find treatments that were administered with success. The Cancer Translational Research Informatics

[Read more →]

by Ed Philips Some basic facts concerning alcoholism include: the disease afflicts nearly 14 million people nationwide, or nearly one in every 10 adults; it kills nearly 20,000 Americans each year, both directly and as a result of alcohol-related incidents and conditions. Nearly one-third of people diagnosed with psychotic disorders show a history of alcoholism and alcohol-dependency. Clearly this disease is devastating in its scope and impact. It is a strain on the public health system and a

[Read more →]

(University of Michigan Health System) University of Michigan researchers have discovered that a key protein in cells plays a critical role in not one, but two processes affecting the development of cancer. source : http://www.eurekalert.org

[Read more →]

Drugs that block new blood vessel formation may help kill sarcomas by preventing their nourishment by the blood vessels. According to a recent article published in the Journal of Clinical Oncology, the addition of Avastin® (bevacizumab) to the chemotherapy agent Adriamycin® (doxorubicin) may slow cancer progression in patients with metastatic soft-tissue sarcomas. Bevacizumab (Avastin) has shown a small benefit in sarcoma patients, when given with doxorubicin and other drugs. One such combinat

[Read more →]

Reuters is reporting on a new study that appeared in the December 29th online edition of the Journal of Clinical Oncology. From Reuters: “Consumption of a diet high in fruits, vegetables, whole grains, and poultry, and low in red meat and refined foods may positively influence a woman’s overall health and prevent other cancers and chronic diseases,” Dr. Marilyn L. Kwan, a researcher at Kaiser Permanente in Oakland, California, told Reuters Health. In addition, we know that in some poor neig

[Read more →]

It is a little difficult to flow or understand health personnel’s when they begin to reel out their terms or jargons when it come to breast cancer related issues. This write-up is intended to water down all the related terms associated with breast cancer; Happy reading: • Adenocarcinoma: Malignant tumor originating in glandular (Relating to or affecting or functioning as a gland) epithelium (Membranous tissue covering internal organs and other internal surfaces of the body). This is a type of

[Read more →]

Health & Medicine Reference “Metastasis is not a passive process,” said cancer biologist Amato Giaccia, PhD. “Cells don’t just break off the primary tumor and lodge someplace else. Instead the cells actually secrete substances to precondition target tissue and make it more amenable to subsequent invasion.” In other words, the cells plan ahead by first sending molecular emissaries to orchestrate a breach in the body’s natural defenses. Blocking this cascade of events in mice hobbled the ce

[Read more →]

Heart failure drug in use for centuries may help treat cancer too January 6th, 2009 The researchers came to this conclusion while researching into existing drugs that might slow or stop cancer progression. “This is really exciting, to find that a drug already deemed safe by the FDA also can inhibit a protein crucial for cancer cell survival,” says Dr. Gregg L. Semenza, director of the vascular program at the Johns Hopkins Institute for Cell Engineering and a member of the McKusick-Nathans I

[Read more →]

Obese postmenopausal women who have never used hormone replacement therapy may face an increased risk of ovarian cancer, compared to normal-weight women, a new study suggests. Interestingly, obese women who have used hormone replacement therapy (HRT) for symptoms of menopause may not face increased risk for this type of malignancy. The study findings are published in the Feb. 15 issue of the journal Cancer. The take-home message is a familiar one, experts said: Maintain a healthy body weight

[Read more →]

YM BIOSCIENCES’ NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL - MSN MoneyCentral YM BIOSCIENCES’ NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL - MSN MoneyCentral Singapore investigators to coordinate 700 patient trial of EGFR targeting antibody for treatment of head and neck cancer MISSISSAUGA, ON , Jan. 5 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Alternext US:YMI, TSX:YM, AIM:YMBA), an oncology Olive Oil: The New Cancer Weapon - KCEN TV NBC 6 Extra-virgin o

[Read more →]